BNP Paribas Asset Management
MED icon

BNP Paribas Asset Management’s Medifast MED Stock Holding History

BNP Paribas Asset Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-854
Closed -$242K – 908
2021
Q2 		$242K Buy
+854
New +$231K ﹤0.01% 875
2015
Q3 		– Sell
-108,551
Closed -$3.51M – 1018
2015
Q2 		$3.51M Buy
108,551
+1,297
+1% +$41.1K 0.03% 586
2015
Q1 		$3.21M Sell
107,254
-9,129
-8% -$290K 0.02% 599
2014
Q4 		$3.9M Sell
116,383
-52,642
-31% -$1.64M 0.03% 484
2014
Q3 		$5.55M Buy
169,025
+9,843
+6% +$302K 0.05% 403
2014
Q2 		$4.84M Buy
159,182
+72,072
+83% +$2.25M 0.04% 474
2014
Q1 		$2.53M Sell
87,110
-237
-0.3% -$6.35K 0.02% 597
2013
Q4 		$2.28M Buy
+87,347
New +$2.24M 0.02% 608

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BNP Paribas Asset Management's MED Position: Q3 2021 in Review

BNP Paribas Asset Management sold out of Medifast (MED) in Q3 2021, closing a stake of 854 shares — an estimated $242K sold.

BNP Paribas Asset Management first reported a position in MED in Q4 2013 and held it in 8 quarters. The position peaked at $5.55M in Q3 2014. 296 funds tracked by Wall St. Rank hold MED as of Q3 2021.

  • BNP Paribas Asset Management reported no remaining Medifast position as of Q3 2021 after selling out during the quarter.
  • BNP Paribas Asset Management sold 854 Medifast shares in Q3 2021, an estimated $242K.
  • BNP Paribas Asset Management first reported a position in Medifast in Q4 2013 and held it in 8 quarters.
  • BNP Paribas Asset Management's Medifast position peaked at $5.55M in Q3 2014.
  • 296 funds tracked by Wall St. Rank held Medifast as of Q3 2021.

Based on BNP Paribas Asset Management's 13F filing for Q3 2021, filed 8 Nov 2021.